{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:56:30Z","timestamp":1777013790825,"version":"3.51.4"},"reference-count":22,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Huntington\u2019s disease (HD) is a neurodegenerative dementia with a well recognised genetic cause. Alcohol misuse is a major environmental factor relevant to numerous neurological presentations, including HD. We explored the effects of alcohol intake on clinical features of HD by means of data from the Enroll-HD, which is a global registry study. A retrospective observational study making use of the Enroll-HD periodic dataset up to 2020 (in accordance with the Enroll-HD guidelines, encompassing 16,120 subjects with the HD gene (CAG expansion &gt; 36), was carried out. This included 180 sites in 21 countries. The study looked at the association of alcohol use with the clinical presentation of HD, specifically looking into the age of first symptoms and HD severity. We also describe a specific case with manifest HD, a participant in the Enroll-HD study, whereby the patient\u2019s obsessionality was central to her pattern of high alcohol intake and to her successful avoidance of alcohol thereafter. A record of past problems with high alcohol intake was more common in the group with manifest HD (9.0%, n = 1121) when compared with the pre-manifest carriers of the HD genetic abnormality (2.3%, n = 339). Age at onset of symptoms was not significantly influenced by current alcohol misuse, or past misuse. The severity of clinical impairments in HD was influenced by alcohol. Patients who reported high alcohol intake in the past had a statistically significant increase in motor impairments, by the Unified Huntington\u2019s Disease Rating Scale total motor score (Kruskal\u2013Wallis, post hoc Dunn\u2019s, p &lt; 0.001), and a significantly higher burden of psychiatric symptoms by the Problem Behaviours Assessment score (Kruskal\u2013Wallis, post hoc Dunn\u2019s, p &lt; 0.01) compared with those not reporting high alcohol use. However, the past alcohol group did not have a lower Mini Mental State Examination score (Kruskal\u2013Wallis, post hoc Dunn\u2019s, p &gt; 0.05) The first symptom of HD, as determined by the assessing clinician, was more likely to be psychiatric disturbance in patients currently misusing alcohol or those with prior history of alcohol misuse (55% and 31% respectively) when compared with controls (5%). Individual case experience, such as that presented in this study, shows that HD and alcohol, two major genetic and environmental contributors to neurodegeneration, interact in producing clinical problems. However, the complexities of these interactions are difficult to define, and may require larger studies dedicated to exploring the various factors in this interaction.<\/jats:p>","DOI":"10.3390\/ijerph18105113","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T10:59:12Z","timestamp":1620817152000},"page":"5113","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Genetic and Environmental Contributors to Neurodegeneration: An Exploration of the Effects of Alcohol on Clinical Features of Huntington\u2019s Disease Using the Enroll-HD Global Platform"],"prefix":"10.3390","volume":"18","author":[{"given":"Alexander L.","family":"Symonds","sequence":"first","affiliation":[{"name":"Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool L9 7LJ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Macerollo","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool L9 7LJ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Foy","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool L9 7LJ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sundus H.","family":"Alusi","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool L9 7LJ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhys","family":"Davies","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool L9 7LJ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/B978-0-12-381328-2.00013-4","article-title":"Huntington\u2019s disease: Clinical presentation and treatment","volume":"98","author":"Novak","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1176\/appi.neuropsych.11030057","article-title":"Longitudinal evaluation of neuropsychiatric symptoms in Huntington\u2019s disease","volume":"24","author":"Thompson","year":"2012","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/jnnp-2012-304636","article-title":"Prevalence of adult Huntington\u2019s disease in the UK based on diagnoses recorded in general practice records","volume":"84","author":"Evans","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s11940-011-0140-y","article-title":"Treatment of Apathy in Huntington\u2019s Disease and Other Movement Disorders","volume":"13","author":"Krishnamoorthy","year":"2011","journal-title":"Curr. Treat. Options Neurol."},{"key":"ref_5","first-page":"644","article-title":"Obsessive-Compulsive Disorder Symptoms in Huntington\u2019s Disease: A Case Report","volume":"37","author":"Herin","year":"2008","journal-title":"Rev. Colomb. Psiquiatr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: Natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1212\/WNL.0000000000003661","article-title":"Substance abuse may hasten motor onset of Huntington disease: Evaluating the Enroll-HD database","volume":"88","author":"Schultz","year":"2017","journal-title":"Neurology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1192\/bjp.114.506.93","article-title":"Social aspects of Huntington\u2019s Chorea","volume":"114","author":"Hans","year":"1968","journal-title":"Br. J. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1192\/bjp.116.532.241","article-title":"Huntington\u2019s chorea in Northamptonshire","volume":"116","author":"Oliver","year":"1970","journal-title":"Br. J. Psychiatry"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1192\/bjp.116.532.255","article-title":"Socio-psychiatric consequences of Huntington\u2019s disease","volume":"116","author":"Dewhurst","year":"1970","journal-title":"Br. J. Psychiatry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1192\/bjp.116.532.259","article-title":"Huntington\u2019s chorea in the West of Scotland","volume":"116","author":"Bolt","year":"1970","journal-title":"Br. J. Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1600-0447.1991.tb05511.x","article-title":"The clinical manifestation of mental disorder in Huntington\u2019s disease: A retrospective case record study of disease progression","volume":"83","author":"Pflanz","year":"1991","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1017\/S0033291700005043","article-title":"Alcohol abuse in Huntington\u2019s disease","volume":"15","author":"King","year":"1985","journal-title":"Psychol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/alzrt157","article-title":"Alcohol-related dementia: An update of the evidence","volume":"5","author":"Ridley","year":"2013","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-018-0453-0","article-title":"Alcohol use and dementia: A systematic scoping review","volume":"11","author":"Rehm","year":"2019","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_16","first-page":"136","article-title":"Unified Huntington\u2019s Disease Rating Scale: Reliability and consistency","volume":"11","author":"Kieburtz","year":"1996","journal-title":"Neurology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0895-4356(97)00060-7","article-title":"Community screening for dementia: The Mini Mental State Exam (MMSE) and Modified Mini-Mental State Exam (3MS) compared","volume":"50","author":"McDowell","year":"1997","journal-title":"J. Clin. Epidemiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.genhosppsych.2007.11.005","article-title":"Behavioural problems in Huntington\u2019s disease using the Problem Behaviours Assessment","volume":"30","author":"Kingma","year":"2008","journal-title":"Gen. Hosp. Psychiatry"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e001909","DOI":"10.1136\/bmjopen-2012-001909","article-title":"Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: A systematic review","volume":"3","author":"Stephan","year":"2013","journal-title":"BMJ Open"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/mds.26838","article-title":"Validation of a prognostic index for Huntington\u2019s disease","volume":"30","author":"Long","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1532-5415.2004.52159.x","article-title":"Alcohol intake and risk of dementia","volume":"52","author":"Luchsinger","year":"2004","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1212\/01.wnl.0000262035.87304.89","article-title":"Alcohol consumption, mild cognitive impairment, and progression to dementia","volume":"68","author":"Solfrizzi","year":"2007","journal-title":"Neurology"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/10\/5113\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:59:36Z","timestamp":1760162376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/10\/5113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,12]]},"references-count":22,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["ijerph18105113"],"URL":"https:\/\/doi.org\/10.3390\/ijerph18105113","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,12]]}}}